Anchalee Avihingsanon

Appearances

WEEK 48 RESULTS OF A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF BICTEGRAVIR/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (B/F/TAF) VS DOLUTEGRAVIR + EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (DTG+F/TDF) IN ART-NAIVE, HIV/HBV-COINFECTED ADULTS (ALLIANCE)
Date
May 7, 2023
The clinical course of HBV in individuals with HIV coinfection is marked by accelerated disease progression…
Speakers
Anchalee Avihingsanon
Hongzhou Lu
Chee Loon Leong
Chien-Ching Hung
Ellen Koenig
Sasisopin Kiertiburanakul
Man-Po Lee
Khuanchai Supparatpinyo
Sophia Rahman
Michelle D'Antoni Brogan
Hongyuan Wang
Hal Martin
Jared Baeten
Fujie Zhang
Presenters
Jason Hindman
Swarup Mehta